Precision Oncology in Northern Germany: Integrating Multi-Omics and Artificial Intelligence to Support Evidence-Based Molecular Tumor Boards
Oncology Research and Treatment · 2026
DOI: 10.1159/000553462 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Oncology Research and Treatment, 2026. Verfasst von Jan Vorwerk und 29 weiteren Autor:innen. Beteiligte Einrichtung: University Cancer Center Schleswig-Holstein (UCC-SH), University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany. Hauptthemen laut MEDLINE: Precision Medicine, Artificial Intelligence, Medical Oncology, Neoplasms. Die Arbeit nennt 123 Literaturangaben.
Abstract (Originalsprache)
Background: The expanding availability of multi-omics profiling and advances in artificial intelligence (AI) and machine learning (ML) are changing precision oncology. Molecular testing strategies such as longitudinal liquid biopsy assessment, germline variant analysis, and the evaluation of tumor-infiltrating clonal hematopoiesis are gaining attention, given their potential to inform treatment decisions from surveillance through therapy selection. Summary: In 2025, during a NORD (Northern Oncology, Research and Development) workshop on “Precision Oncology,” stakeholders from three Northern German University hospitals exchanged insights on the impact of tumor heterogeneity and the tumor microenvironment, approaches for multi-layer data integration, and strategies to accelerate translation using innovative clinical trial designs. Building on this discussion, participants evaluated how the integration of multi-omics data, AI, and ML into Molecular Tumor Board (MTB) workflows could enhance decision-making, as well as the challenges associated with implementing these tools in routine clinical care. The workshop thereby not only identified key opportunities and obstacles but also formulated recommendations on how these tools can be stepwise integrated into existing workflows to generate the evidence required for their implementation in clinical practice. Key Messages: This review connects expert perspectives with targeted literature to outline how these emerging methods advance precision oncology. It further identifies the technical, structural, and clinical requirements for their implementation in clinical use, and highlights how they can improve the quality, speed and accessibility of MTB recommendations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- University Cancer Center Schleswig-Holstein (UCC-SH), University Medical Center Schleswig-Holstein, Kiel and Lübeck, Germany.
- Department of Hematology and Oncology, University Medical Center Schleswig-Holstein - Campus Lübeck, Lübeck, Germany.
- University Cancer Center Hamburg (UCC Hamburg), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Oncology, Hematology, and Bone Marrow Transplantation with the Section Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Mildred Scheel Early Career Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
- Department of Urology, University Medical Center Schleswig-Holstein - Campus Kiel, Kiel, Germany.
Zitieren
APA
Vorwerk, J., Leypoldt, L., Schwandt, J., Kohler, J., Nimmagadda, S. C., Ahmed, H., Patnana, P. K., Hönemann, H., Helbing, T., Feierabend, S., Dazert, E., Oelschläger, L., Beder, T., Bastian, L., Sommer, F., Zech, H., Kriegs, M., Dauth, A., Ailani, D., …, & Huber, K. (2026). Precision Oncology in Northern Germany: Integrating Multi-Omics and Artificial Intelligence to Support Evidence-Based Molecular Tumor Boards. Oncology Research and Treatment. https://doi.org/10.1159/000553462
Vancouver
Vorwerk J, Leypoldt L, Schwandt J, Kohler J, Nimmagadda SC, Ahmed H, et al. Precision Oncology in Northern Germany: Integrating Multi-Omics and Artificial Intelligence to Support Evidence-Based Molecular Tumor Boards. Oncology Research and Treatment. 2026. doi:10.1159/000553462
BibTeX
@article{Vorwerk2026,
author = {Vorwerk, Jan and Leypoldt, Lisa and Schwandt, Johanna and Kohler, Jakob and Nimmagadda, Subbaiah Chary and Ahmed, Helal and Patnana, Pradeep Kumar and Hönemann, Helene and Helbing, Theresa and Feierabend, Sabrina and Dazert, Eva and Oelschläger, Lorenz and Beder, Thomas and Bastian, Lorenz and Sommer, Felix and Zech, Henrike and Kriegs, Malte and Dauth, Alice and Ailani, Deepak and Albers-Leischner, Corinna and Christopeit, Maximilian and Heckl, Steffen and Busch, Hauke and Habig, Sarah and Ückert, Frank and Fliedner, Stephanie M J and Gebauer, Niklas and von Bubnoff, Nikolas and Khandanpour, Cyrus and Huber, Karin},
title = {Precision Oncology in Northern Germany: Integrating Multi-Omics and Artificial Intelligence to Support Evidence-Based Molecular Tumor Boards},
journal = {Oncology Research and Treatment},
year = {2026},
doi = {10.1159/000553462}
}
EUVIMED